<code id='65A22AF129'></code><style id='65A22AF129'></style>
    • <acronym id='65A22AF129'></acronym>
      <center id='65A22AF129'><center id='65A22AF129'><tfoot id='65A22AF129'></tfoot></center><abbr id='65A22AF129'><dir id='65A22AF129'><tfoot id='65A22AF129'></tfoot><noframes id='65A22AF129'>

    • <optgroup id='65A22AF129'><strike id='65A22AF129'><sup id='65A22AF129'></sup></strike><code id='65A22AF129'></code></optgroup>
        1. <b id='65A22AF129'><label id='65A22AF129'><select id='65A22AF129'><dt id='65A22AF129'><span id='65A22AF129'></span></dt></select></label></b><u id='65A22AF129'></u>
          <i id='65A22AF129'><strike id='65A22AF129'><tt id='65A22AF129'><pre id='65A22AF129'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:4842
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In
          Previous article: 'Vaccine
          Next article: How one medical school became remarkably diverse

          Wikipedia

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Pfizer is about to make a big push in cancer. Will investors listen?
          Pfizer is about to make a big push in cancer. Will investors listen?

          PfizerCEOAlbertBourlaGiannisPapanikos/APPfizerhasabigproblem.Thedruggianthopesthatnewdrugstotreatcan

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Using force crossed my mind when examining a defiant young patient

          Inthis1895photo,nursesanddoctorsinoculateachildwithdiphtheriaantitoxinatthePasteurInstituteinNewYork